MedPath

Effect of clozapine and olanzapine on the use of drugs and alcohol by patients with schizophrenia and related disorders

Conditions
schizophreniasubstance abuse or dependenceclozapineolanzapinedouble blindrandomized
Registration Number
NL-OMON21845
Lead Sponsor
ZonMW
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
140
Inclusion Criteria

1. Diagnosis of schizophrenia or schizoaffective disorder or schizophreniform disorder according to DSM-IV with
the Structured Clinical Interview for the Diagnostic and
Statistical Manual of Mental Disorders (SCID-P)

Exclusion Criteria

Detailed exclusion criteria

1. Pregnancy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary efficacy measures: <br /><br>at baseline, week 4, week 8, month 6 and at moment of unblinding:<br /><br>Self reported drug use<br /><br>- CIDI SAM: self-report substance use <br /><br>- Recent Drug Use Urinalysis (RDUU): a laboratory semiquantitative test on the presence of cannabis, heroin,cocaine and amphetamines (including XTC)<br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath